Bibliometric Analysis of Global Scientific Production on COVID-19 and Vaccines

This bibliometric analysis aims to analyze the global scientific production of COVID-19 and vaccines. First, a search for scientific articles was performed using the advanced query in the Web of Science™ database, more precisely in its core collection, on 18 February 2023. Data from 7754 articles were analyzed using the Bibliometrix R package and the Biblioshiny application. The evaluated articles were published mainly in 2022 (60%). The scientific journals that published the most about COVID-19 and vaccines were “Vaccines”, “Vaccine” and “Human Vaccines & Immunotherapeutics”. The University of Oxford was the most productive institution, with the authors of the articles mainly originating from the United States, China and the United Kingdom. The United States, despite having carried out the most significant number of collaborations, published mainly with local researchers. The 15 most cited articles and the KeyWords Plus™ evidenced the focus of the published articles on the safety and efficacy of vaccines against COVID-19, as well as on the evaluation of vaccine acceptance, more specifically on vaccine hesitancy. Research funding came primarily from US government agencies.

[1]  S. Jeon,et al.  COVID-19 Vaccination: Sociopolitical and Economic Impact in the United States , 2022, Epidemiolgia.

[2]  Sun Kyong Lee,et al.  Misinformation of COVID-19 vaccines and vaccine hesitancy , 2022, Scientific Reports.

[3]  S. Gharbia,et al.  Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.

[4]  Christina C. Chang,et al.  mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant , 2022, Cell.

[5]  Christina C. Chang,et al.  mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant , 2021, medRxiv.

[6]  P. Kaleebu,et al.  Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts , 2021, International Journal of Infectious Diseases.

[7]  A. Dehshahri,et al.  A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines , 2021, International Immunopharmacology.

[8]  J. Mascola,et al.  Accelerated COVID-19 vaccine development: milestones, lessons, and prospects , 2021, Immunity.

[9]  R. Myers,et al.  Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant , 2021, The New England journal of medicine.

[10]  Laurin B. Weissinger,et al.  COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries , 2021, Nature Medicine.

[11]  D. Swerdlow,et al.  Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data , 2021, The Lancet.

[12]  D. Alcendor,et al.  Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity , 2021, Vaccines.

[13]  H. Fennema,et al.  Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 , 2021, The New England journal of medicine.

[14]  A. Arslanoğlu,et al.  A 50-Year Overview of the Coronavirus Family with Science Mapping Techniques: A Review , 2021, Iranian journal of public health.

[15]  Dorra Yahiaoui,et al.  Entrepreneurial universities: A bibliometric analysis within the business and management domains , 2021, Technological Forecasting and Social Change.

[16]  Cynthia Liu,et al.  A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development , 2021, ACS central science.

[17]  M. Jit,et al.  COVID-19 vaccine challenges: What have we learned so far and what remains to be done? , 2021, Health Policy.

[18]  S. Madhi,et al.  Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant , 2021, The New England Journal of Medicine.

[19]  C. Latkin,et al.  COVID-19 vaccine intentions in the United States, a social-ecological framework , 2021, Vaccine.

[20]  M. Hernán,et al.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting , 2021, The New England journal of medicine.

[21]  S. Hernández-Díaz,et al.  COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries , 2021, European Journal of Epidemiology.

[22]  V. Gushchin,et al.  Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia , 2021, The Lancet.

[23]  M. E. B. Moura,et al.  Analysis of scientific production on the new coronavirus (COVID-19): a bibliometric analysis , 2021, Sao Paulo medical journal = Revista paulista de medicina.

[24]  A. Sheikh,et al.  COVID-19 Vaccine Acceptance among Health Care Workers in the United States , 2021, medRxiv.

[25]  Nguyen H. Tran,et al.  Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK , 2020, Lancet.

[26]  Joe Hasell,et al.  Coronavirus disease (COVID-19) , 2020, Arab Society: A Compendium of Social Statistics.

[27]  Graham Lawton Sputnik V , 2021, New Scientist.

[28]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[29]  Mujeeb Khan,et al.  COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far , 2020, Molecules.

[30]  A. Pollard,et al.  A guide to vaccinology: from basic principles to new developments , 2020, Nature reviews. Immunology.

[31]  Jon Cohen Shots of hope. , 2020, Science.

[32]  L. Wong,et al.  Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. , 2020, PLoS neglected tropical diseases.

[33]  S. Lewandowsky,et al.  COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II , 2020, Psychological Medicine.

[34]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[35]  M. Aria,et al.  The scholar’s best friend: research trends in dog cognitive and behavioral studies , 2020, Animal Cognition.

[36]  Lawrence O Gostin,et al.  A global survey of potential acceptance of a COVID-19 vaccine , 2020, Nature Medicine.

[37]  E. Walsh,et al.  Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates , 2020, The New England journal of medicine.

[38]  Diego Carrión-Álvarez,et al.  Fake news in COVID-19: A perspective , 2020, Health promotion perspectives.

[39]  R. Baric,et al.  Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults , 2020, The New England journal of medicine.

[40]  Ziqin Deng,et al.  Bibliometric and Visualization Analysis of Human Coronaviruses: Prospects and Implications for COVID-19 Research , 2020, Frontiers in Cellular and Infection Microbiology.

[41]  S. Crawford,et al.  Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults , 2020, Annals of Internal Medicine.

[42]  Jiahao Wang,et al.  Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China , 2020, Vaccines.

[43]  M. Pennell,et al.  Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? , 2020, Vaccine.

[44]  E. Walsh,et al.  Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults , 2020, Nature.

[45]  A. Okoh,et al.  Global research trends on bioflocculant potentials in wastewater remediation from 1990 to 2019 using a bibliometric approach , 2020, Letters in applied microbiology.

[46]  L. Wong,et al.  The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay , 2020, Human vaccines & immunotherapeutics.

[47]  Nguyen H. Tran,et al.  Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial , 2020, The Lancet.

[48]  J. Mascola,et al.  An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.

[49]  R. Owens,et al.  Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 , 2020, npj Vaccines.

[50]  A. Dror,et al.  Vaccine hesitancy: the next challenge in the fight against COVID-19 , 2020, European Journal of Epidemiology.

[51]  Robert T. Chen,et al.  Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines , 2020, Vaccine.

[52]  Young Chan Kim,et al.  COVID-19 vaccines: breaking record times to first-in-human trials , 2020, npj Vaccines.

[53]  Zacharias E. Andreadakis,et al.  The COVID-19 vaccine development landscape , 2020, Nature Reviews Drug Discovery.

[54]  Longxiang Xie,et al.  Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV , 2020, Viruses.

[55]  O. Launay,et al.  [History and principles of vaccination]. , 2019, Revue des maladies respiratoires.

[56]  Vincent A. Traag,et al.  From Louvain to Leiden: guaranteeing well-connected communities , 2018, Scientific Reports.

[57]  A. Okoh,et al.  A global bibliometric analysis of Plesiomonas-related research (1990 – 2017) , 2018, PloS one.

[58]  O. Dada A Model of Entrepreneurial Autonomy in Franchised Outlets: A Systematic Review of the Empirical Evidence , 2018 .

[59]  Massimo Aria,et al.  bibliometrix: An R-tool for comprehensive science mapping analysis , 2017, J. Informetrics.

[60]  H. Larson,et al.  The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. , 2017, Vaccine.

[61]  Andrea Rey-Martí,et al.  A bibliometric analysis of social entrepreneurship , 2016 .

[62]  X. Bosch-Capblanch,et al.  Exposing concerns about vaccination in low- and middle-income countries: a systematic review , 2015, International Journal of Public Health.

[63]  N. MacDonald Vaccine hesitancy: Definition, scope and determinants. , 2015, Vaccine.

[64]  Ivan Zupic,et al.  Bibliometric Methods in Management and Organization , 2014 .

[65]  John McCormick,et al.  The Member States , 2011 .

[66]  M. Huycke Smallpox in the post-eradication era. , 2002, The Journal of the Oklahoma State Medical Association.

[67]  Eugene Garfield,et al.  KeyWords Plus™—algorithmic derivative indexing , 1993 .

[68]  J. J. Hubert Linguistic indicators , 1980 .

[69]  R. B.,et al.  The United Nations , 1947, Nature.